![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/107 | |
A61K 31/197 | |||
A61K 9/50 | |||
A61K 47/10 | |||
A61K 47/12 | |||
A61K 47/14 | |||
A61K 9/00 | |||
A61K 9/16 | |||
A61K 9/20 | |||
A61K 9/48 |
(11) | Number of the document | 2861216 |
(13) | Kind of document | T |
(96) | European patent application number | 13729029.2 |
Date of filing the European patent application | 2013-06-14 | |
(97) | Date of publication of the European application | 2015-04-22 |
(45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/062398 |
Date | 2013-06-14 |
(87) | Number | WO 2013/186370 |
Date | 2013-12-19 |
(30) | Number | Date | Country code |
1255593 | 2012-06-14 | FR |
(72) |
AILHAS, Caroline, FR
HERRY, Catherine, FR
|
(73) |
Ethypharm,
194 Bureaux de la Colline Bātiment D, 92210 Saint-Cloud,
FR
|
(54) | FORMULATION PHARMACEUTIQUE ORALE DE MOLECULES BCS DE CLASSE III |
ORAL PHARMACEUTICAL FORMULATION OF BCS CLASS III MOLECULES |